Karim Haddad (@kh_reader_onco) header
Karim Haddad (@kh_reader_onco) profile picture

محب للأورام، راكب دراجات في نهاية الأسبوع، قارئ نهم. 🚴📚

Beirut
Joined March 2023
📗 Our latest #CancerScope covers a phase 3 trial showing that teclistamab significantly improved progression-free survival & overall survival in patients with r/r #MultipleMyeloma who received 1 to 3 previous lines of therapy. 🔗: acsjournals.onlinelibrary.wi… @OncoAlert #MMSM
6
5
432
Now online: Identification of Proteomic Subtypes with Differential Responses to Immune Checkpoint Inhibition in Cutaneous Melanoma doi.org/10.1158/1078-0432.CC…
2
2
146
Karim Haddad retweeted
Join us today from 4-5 pm
Honored to present our approach to robotic simultaneous kidney-pancreas transplantation at this Wednesday's ASTS Surgical Skills Webinar, with Dr. Mario Spaggiari and @DocWak as panelists. Please join us: members.asts.org/Events/even… @ASTSChimera @amjtransplant
1
10
514
Karim Haddad retweeted
Cooperativity between TFs is one of the main explanations of the TF specificity problem. In our new preprint, we used BPNet GRAMMAR models trained on ~2,000 ENCODE TF binding profiles to systematically assess motif cooperativity. biorxiv.org/content/10.64898…
1
5
25
1,790
How did pneumonitis go from a major worry to a success story with T-DXd? Dr. Seth Wander tells Dr. Paolo Tarantino (@PTarantinoMD) how the original phase 2 data in treatment-refractory HER2-positive breast cancer showed higher rates of higher-grade pneumonitis. Clinicians then started anticipating it. Through the phase 3 data in the second line, and now in the adjuvant and first-line settings, the grades of pneumonitis have shifted lower. The reason is vigilance: clinicians know it can happen, so they watch for it on CT and intervene before any clinical symptoms or problems with oxygenation. He calls it a huge success story, though pneumonitis still happens and close CT monitoring is key. 🎥 Watch the full conversation: communityhealth.media/tdxd-h… 💬 How often do you image patients on T-DXd to catch ILD early?
5
4
686
The end of #CervicalCancer is in sight. We have the tools to eliminate it: HPV vaccination, screening and timely treatment. Six years ago, @WHO Member States adopted a global strategy with ambitious targets: 90% HPV vaccination, 70% screening and 90% access to treatment. Since then, vaccine supply has improved, 166 countries have introduced HPV vaccination, and a simplified single-dose schedule has made it easier and more affordable to reach girls. HPV testing and treatment are also expanding. On #WorldCervicalCancerEliminationDay, Dr Princess Nono Simelela, my colleagues and I have a simple message: The tools exist. The strategy is clear. The momentum is real. Cervical cancer elimination is within our reach. With science, solidarity and sustained commitment, we can make it a reality. telegraph.co.uk/global-healt…
7
60
2
118
16,857
Karim Haddad retweeted
#Cardiothoracic residents can apply to receive funding for valvular heart disease, mesothelioma and lung cancer, and AI and data science research through an AATS Foundation Fall Award. Submissions are due in two weeks. Apply by December 1: hubs.la/Q04Fqr_r0
2
1
5
983
Karim Haddad retweeted
The new issue of #ScienceSignaling has arrived! New experiments may explain how drinking alcohol weakens the tumor-killing capabilities of cancer immunotherapy, a large dataset teases out tissue-specific responses to therapeutic interferons, and more. scim.ag/4C8nJEu
3
1
8
7,656
A new @ScienceAdvances analysis identifies a set of environmental exposures that have an outsized impact on early life. scim.ag/4C15eSq
1
3
24
12,456
Karim Haddad retweeted
New in Nature Cancer: CAR-T cells with a radiation-inducible promoter, so TNF is released only where the beam goes. High TNF in the tumor, none in serum. doi.org/10.1038/s43018-026-0… I was lucky to be part of this team. I learned a great deal from them and it was a valuable time for me. CAR-T plus RT is still not a familiar combination in our field, but I think it could become another weapon for rad onc. We already know RT has systemic effects, immune mediated but hard to predict. This is a different trigger: the beam switches on a gene in a cell we built. Putting dose exactly where we want it is the one thing we are good at. This is one way to use that precision for something other than local control. Congrats to Elham, Ainhoa and @rweichselbaum. Years of work finally landed. Always rooting for what comes out of that lab next, and I will be waiting for it.
8
10
65
3,479
Peer reviews are awash in AI-generated feedback, and disclosure policies aren’t working. Jessica Hullman argues peer review needs centralized AI checks, reviewer accountability, and desk rejects for AI slop statmodeling.stat.columbia.e…
2
2
1
6
467
"Global Security requires health security, which not only includes domestic readiness, but also global cooperation that should not be dependent on political winds," writes Seth Berkley in a new #ScienceExpertVoices article. scim.ag/4zhBiyA
1
7
1
14
12,660
New guidelines, ongoing gap: Despite recommendations supporting statin use in CKD, treatment remains underused, especially in advanced disease. This #researchletter in #ASNCJASN highlights a risk-treatment paradox and opportunities to improve cardiovascular prevention in CKD. kidney.pub/CJASN1218
12
15
1,822
.@WHO’s credibility rests on the quality of our science. Our scientific integrity matters more than our income. Nine years ago, we made science leadership a priority in WHO's transformation, establishing the Science Division and Science Council. At today's Science Council meeting, I reaffirmed our commitment to stand by the evidence, even when it comes at a financial cost. As science moves to the forefront of health diplomacy, WHO must not only keep pace with scientific advances, but anticipate and shape them, build trust and ensure evidence serves those who need it most. My thanks to Professor Thomas Südhof for agreeing to chair the Council and Dr Jeanine Condo for serving as the Vice-chair.
24
46
3
112
21,827
Karim Haddad retweeted
Just published in ctRO, Clinical and Translational Radiation Oncology: ESTRO #guideline on #radiotherapy in Merkel cell #carcinoma 👉 bit.ly/48lus0i #Radonc #SkinCancer
1
14
1
23
1,628
Karim Haddad retweeted
Academic research depends on public funds, generally obtained through competitive applications. In this ecrLife blog, Luigi Capoani uses European case studies to weigh up the strengths and limitations of competitive funding. bit.ly/4Aw6Vpm
3
3
1,774
Dismissing patients over supplements is bad practice, I don't know a single colleague who does it. Crediting ivermectin with a remission with zero trial evidence is worse. Spontaneous responses happen. One screenshot is not data #clinicaltrials
This Post is from a suspended account. Learn more
28
Really nice characterization work 2-keto-D-glucose, furaldehyde, methylglyoxal & acetaldehyde identified under gas plasma treatment methylglyoxal the standout given its established anticancer activity solid groundwork for #PlasmaMedicine
This study characterized glucose oxidation products formed under gas plasma treatment across biomedically relevant glucose levels. Identified products included 2-keto-D-glucose, furaldehyde, methylglyoxal & acetaldehyde 🧪🔬 #GlucoseOxidation #GasPlasma mdpi.com/2227-9059/13/11/283…
11
Blood cells don't fossilize very easily. Most break down shortly after death, and certain minerals can mimic the blobby shape of cells under a microscope, making the prospect of finding convincing traces of very ancient blood—say, as old as dinosaurs—far-fetched. Yet that's what scientists say they've uncovered. With multiple lines of evidence, the international team behind the new study claims the remains from a 115-year-old dinosaur from Brazil contain the oldest fossilized red blood cells ever discovered. But some experts remain skeptical. Learn more: scim.ag/4eYu1wq @NewsfromScience
5
23
3
125
22,696